Former college swimmer Riley Gaines repeatedly mocked Rep. Alexandria Ocasio-Cortez, D-N.Y., on social media on Thursday ...
Kronos Bio has given up on its only drug in clinical trials after some patients suffered neurological problems like ...
The final battle was waged last week when President-elect Donald Trump won victory. As some conservatives explain it, the ...
GSK is the fifth company to leave BIO in roughly a year, a group that includes Pfizer and UCB. The departures coincided with ...
Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...
The company ended the quarter with $192 million in cash and equivalents, enough to fund operations past 2027. 2seventy Bio ...
Secures $3.2m in PIPE Financing -- $50m Term Sheet Obtained for Available Financing under Equity Line of Credit -BOSTON and LONDON, Nov. 14, ...
"AOC removing the pronouns from her bio is a hell of a vibe shift," one social media user posted. X's community notes, ...
MEMS, wearable/implantable electronics and bio-tissue therapeutics, the pursuit of piezoelectric biomaterials has become a ...
On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...
The European Commission is asking biopharma and manufacturing companies about their reaction to Novo ...
The European Medicines Agency has flipped its stance on Eisai and Biogen’s Alzheimer’s treatment Leqembi, recommending ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback